Coldstream Capital Management Inc Tarsus Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 12 shares of TARS stock, worth $576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$576% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
40MCall Options Held
29.8KPut Options Held
29.4K-
Rtw Investments, LP New York, NY3.32MShares$159 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$157 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$122 Million5.35% of portfolio
-
Jennison Associates LLC2.49MShares$120 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$108 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.28B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...